Literature DB >> 27084773

Morin Mitigates Chronic Constriction Injury (CCI)-Induced Peripheral Neuropathy by Inhibiting Oxidative Stress Induced PARP Over-Activation and Neuroinflammation.

Prashanth Komirishetty1, Aparna Areti1, Ramakrishna Sistla2, Ashutosh Kumar3.   

Abstract

Neuropathic pain is initiated or caused due to the primary lesion or dysfunction in the nervous system and is proposed to be linked to a cascade of events including excitotoxicity, oxidative stress, neuroinflammation and apoptosis. Oxidative/nitrosative stress aggravates the neuroinflammation and neurodegeneration through poly (ADP) ribose polymerase (PARP) overactivation. Hence, the present study investigated the antioxidant and anti-inflammatory effects of the phytoconstituent; morin in chronic constriction injury (CCI) induced neuropathy. Neuropathic pain was induced by chronic constriction of the left sciatic nerve in rats, and the effect of morin (15 and 30 mg/kg, p.o.) was evaluated by measuring behavioural and biochemical changes. Mechanical, chemical and thermal stimuli confirmed the CCI-induced neuropathic pain and treatment with morin significantly improved these behavioural deficits and improved the sciatic functional index by the 14th day after CCI induction. After 14 days of CCI induction, oxidative/nitrosative stress and inflammatory markers were elevated in rat lumbar spinal cord. Oxidative stress induced PARP overactivation resulted in depleted levels of ATP and elevated levels of poly (ADP) ribose (PAR). Treatment with morin reduced the levels of nitrites, restored glutathione levels and abrogated the oxidant induced DNA damage. It also mitigated the increased levels of TNF-α and IL-6. Protein expression studies confirmed the PARP inhibition and anti-inflammatory activity of morin. Findings of this study suggest that morin, by virtue of its antioxidant properties, limited PARP overactivation and neuroinflammation and protected against CCI induced functional, behavioural and biochemical deficits.

Entities:  

Keywords:  Chronic constriction injury; Morin; Neuroinflammation; Oxidative stress; PARP

Mesh:

Substances:

Year:  2016        PMID: 27084773     DOI: 10.1007/s11064-016-1914-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  69 in total

1.  Aloperine attenuated neuropathic pain induced by chronic constriction injury via anti-oxidation activity and suppression of the nuclear factor kappa B pathway.

Authors:  Ya-Qiong Xu; Shao-Ju Jin; Ning Liu; Yu-Xiang Li; Jie Zheng; Lin Ma; Juan Du; Ru Zhou; Cheng-Jun Zhao; Yang Niu; Tao Sun; Jian-Qiang Yu
Journal:  Biochem Biophys Res Commun       Date:  2014-08-12       Impact factor: 3.575

2.  Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats.

Authors:  Mohammad S Ola; Abdulaziz M Aleisa; Salim S Al-Rejaie; Hatem M Abuohashish; Mihir Y Parmar; Abdullah S Alhomida; Mohammed M Ahmed
Journal:  Neurol Sci       Date:  2014-01-11       Impact factor: 3.307

3.  Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.

Authors:  Reddemma Sandireddy; Veera Ganesh Yerra; Prashanth Komirishetti; Aparna Areti; Ashutosh Kumar
Journal:  Cell Mol Neurobiol       Date:  2015-09-23       Impact factor: 5.046

4.  Both motor and sensory abnormalities contribute to changes in foot posture in an experimental rat neuropathic model.

Authors:  Heung Sik Na; Young Wook Yoon; Jin Mo Chung
Journal:  Pain       Date:  1996-09       Impact factor: 6.961

5.  Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats.

Authors:  Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Eur J Pharmacol       Date:  2010-09-16       Impact factor: 4.432

6.  Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway.

Authors:  Krishnendu Sinha; Pritam Sadhukhan; Sukanya Saha; Pabitra Bikash Pal; Parames C Sil
Journal:  Biochim Biophys Acta       Date:  2015-01-17

7.  Effect of morin on tissue lipid peroxidation and antioxidant status in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis.

Authors:  Vennila Sreedharan; Karthik Kumar Venkatachalam; Nalini Namasivayam
Journal:  Invest New Drugs       Date:  2008-05-22       Impact factor: 3.850

8.  Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats.

Authors:  Arunachalam Muthuraman; Amteshwar Singh Jaggi; Nirmal Singh; Dhandeep Singh
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

9.  Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

Authors:  Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

Review 10.  Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.

Authors:  Aparna Areti; Veera Ganesh Yerra; Vgm Naidu; Ashutosh Kumar
Journal:  Redox Biol       Date:  2014-01-18       Impact factor: 11.799

View more
  12 in total

1.  Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.

Authors:  Aparna Areti; Prashanth Komirishetty; Anil Kumar Kalvala; Karthika Nellaiappan; Ashutosh Kumar
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

Review 2.  PARP overactivation in neurological disorders.

Authors:  Vijay Kumar Arruri; Chayanika Gundu; Islauddin Khan; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Mol Biol Rep       Date:  2021-03-25       Impact factor: 2.316

Review 3.  Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Rezaul Islam; Sheikh Shohag; Saikat Mitra; Saad Alghamdi; Ahmad O Babalghith; Abdulrahman Theyab; Mohammad Tauhidur Rahman; Aklima Akter; Abdullah Al Mamun; Fahad A Alhumaydhi; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-21       Impact factor: 2.650

4.  E3 Ubiquitin Ligase c-cbl Inhibits Microglia Activation After Chronic Constriction Injury.

Authors:  Pengfei Xue; Xiaojuan Liu; Yiming Shen; Yuanyuan Ju; Xiongsong Lu; Jinlong Zhang; Guanhua Xu; Yuyu Sun; Jiajia Chen; Haiyan Gu; Zhiming Cui; Guofeng Bao
Journal:  Neurochem Res       Date:  2018-06-22       Impact factor: 3.996

Review 5.  Poly(ADP-ribose) polymerase inhibition reveals a potential mechanism to promote neuroprotection and treat neuropathic pain.

Authors:  Prashanth Komirishetty; Aparna Areti; Ranadeep Gogoi; Ramakrishna Sistla; Ashutosh Kumar
Journal:  Neural Regen Res       Date:  2016-10       Impact factor: 5.135

Review 6.  Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.

Authors:  Palanivel Ganesan; Palanisamy Arulselvan; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2017-02-09

Review 7.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

8.  Bromelain reduced pro-inflammatory mediators as a common pathway that mediate antinociceptive and anti-anxiety effects in sciatic nerve ligated Wistar rats.

Authors:  Ahmed O Bakare; Bamidele V Owoyele
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

9.  Metformin relieves neuropathic pain after spinal nerve ligation via autophagy flux stimulation.

Authors:  Weidong Weng; Chenglun Yao; Keshav Poonit; Xijie Zhou; Chao Sun; Feng Zhang; Hede Yan
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

Review 10.  In Vitro and In Vivo Effects of Flavonoids on Peripheral Neuropathic Pain.

Authors:  Paramita Basu; Arpita Basu
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.